Colicins are protein toxins produced by and toxic to Escherichia coli strains. Colicin D consists of an N-terminal domain (NTD), central domain (CD) and C-terminal RNase domain (CRD). The cognate immunity protein, ImmD, is co-synthesized in producer cells to block the toxic tRNase activity of the CRD. Previous studies have reported the crystal structure of CRD/ ImmD complex. Colicin D hijacks the surface receptor FepA and the energy transducer TonB system using the NTD for translocation across the outer membrane of the target cells. The CD is required for endoproteolytic processing and the translocation of CRD across the inner membrane, and the membrane-associated protease FtsH and the signal peptidase LepB are exploited in this process. Although several regions of the CD have been identified in interactions with the hijacked inner membrane system or immunity protein, the structural basis of the CD is unknown. In this study, we determined the crystal structure of colicin D, containing both the CD and CRD. The full-length colicin D/ ImmD heterodimer structure was built by superimposing the CD-CRD structure with the previously determined partial structures. The overall translocation process of colicin D, including the interaction between CD and LepB, is discussed.
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Bacteriocins are protein toxins produced by some bacteria and are used as a means to compete against other bacterial cells (1). Colicins are bacteriocins encoded by colicinogenic plasmids (Col-plasmid) and are widely distributed in natural populations of Escherichia coli and related bacteria (2) . The expression of colicin is controlled by the SOS-responsive promoter and is induced by environmental stress, such as DNA damage. After production, colicin is secreted from the host cells to the medium and is then translocated into sensitive cells via the specific outer membrane receptor, which renders a narrow spectrum of killing activity (3) . The modes of toxic action for most colicins are divided into three types, such as pore-forming, DNase and RNase types (46) . Among the RNase types, colicins E3, E4 and E6 are rRNases that cleave 16S-rRNA, and E5 and D are tRNases that cleave specific tRNAs. Colicins are composed of multiple (generally two or three) domains with three types of functions: receptor-binding activity, membrane transport (or translocation) activity and toxic activity. A Col plasmid of a nuclease-type colicin additionally produces the specific inhibitor protein, Imm, which is encoded by the genes located downstream of col genes within the colicin operons (7) . On induction of a nuclease-type colicin, Imm binds to the toxin domain of the newly synthesized colicin to protect the producer cell from lethality. Even in an uninduced state, a small amount of colicin, which is sufficient to kill sensitive cells, is spontaneously produced in the medium. Under such conditions, the colicinogenic cell produces a basal level of Imm to protect against the action of exogenous cognate colicin, and this phenomenon is referred to as 'immunity' (810). Thus, colicins act to compete with other bacteria that do not possess the same or cognate Col plasmid.
Colicins are divided into two groups (A and B), according to energy-linked import systems after binding to receptors (11, 12) . Group A, including colicins E1, E2E9, K and N, mostly uses the TolA-associated system (TolA/ TolQR). Several group A colicins (e.g. E2E9) require the BtuB receptor. The N-terminal region of group A colicins often consists of two structurally identifiable domains with separate functions: outer membrane translocation (T-domain) and receptor binding (R-domain) (13) . Group B, including colicins B, D, Ia, Ib and M, uses the TonB-associated systems (TonB/ExbBD) and is mainly dependent on the FepA, FhuA or Cir receptor. The two well-studied group B colicins, colicins D and B, use the FepA receptor and the TonB system (1417). The N-terminal 'import (T + R) domain' of colicins B and D (Fig. 1A ) is multifunctional and is used for both receptor binding and translocation across the outer membrane. Since the C-terminal domain of colicin B exhibits pore-forming activity, colicin B has no structurally delineated central domain required for inner membrane translocation (Fig. 1A, top) . The two domains are sufficient for cellkilling activity. The full-length crystal structure of colicin B has been reported previously (Fig. 1B) (18) .
Colicin D specifically cleaves the four isoaccepting E. coli tRNA Arg s at the position between 38 and 39, the 3 0 of the anticodon-loop, and inactivates the protein biosynthetic machinery (19) . Colicin D consists of the N-terminal domain (NTD), central domain (CD) and C-terminal RNase domain (CRD) (Fig. 1A,  lower) . The N-terminal 313 amino acid residues are almost identical (>95% amino acid sequence identity) to the NTD of colicin B (10) . The NTDs of colicins B and D are functionally exchangeable, and their functions are associated with receptor binding and importing the colicin molecule to the periplasm to interact with TonB (16) . It was suggested that the remaining C-terminal region of colicin D includes CRD (10) . The C-terminal fragment, which corresponds to residues 590697 of colicin D, was detected in cells challenged by colicin D (20) . Additionally, biochemical analyses revealed that the C-terminal region contains the CRD (21, 22). Previously, the heterodimeric crystal structures of the CRD (591697 or 595697) and the specific inhibitor of colicin D, ImmD (94 residues), were determined ( Fig. 1C) (21, 23) . Our recent study using colicins D and E5 suggested that specific tRNA cleavage serves as a means to induce bacteriostasis in sensitive cells (24) . Moreover, the ectopic expression of colicin D in the cytosol and mitochondria of eukaryotic cells demonstrated the reversible regulation of cell growth and mitochondrial dysfunction, respectively (2527).
The C-terminal part of colicin B from residue 314 forms a single domain homologous to the C-terminal pore-forming domain of colicin A. The CD of colicin D, without a counterpart in colicin B, is related to the import of CRD to the cytoplasm after interaction with the TonB system, followed by proteolytic processing. The involvement of FtsH in colicin processing was first suggested following isolation of the tolZ mutant, which was tolerant to colicins E2, E3 and D, as a unique colicin-insensitive mutant across the two colicin groups A and B (2830). Independent of this early finding, two research groups revealed that FtsH is required for the processing of nuclease colicins (20, 31) . In addition, in the case of colicin D, a specific interaction between the type I signal (leader) peptidase, LepB and a part of the CD (residues 410437) has been shown to be important for inner membrane translocation (32) . It has been suggested that there is a secondary interaction at a part of the CD (residues 377421) with TonB, in addition to the primary TonB box (residues 1721) in the NTD (17) . However, the mechanism of the processing and translocation of the CRD from the periplasm to the cytoplasm remains obscure because the three-dimensional structure of the CD is not available. Here, we report the crystal structure of colicin D containing both the CD and CRD (313697), providing the first three-dimensional structure of the CD. Moreover, the full-length colicin D structure was modelled by superposing the CD-CRD structure with the almost identical N-terminal import domain in the colicin B structure (18) . Based on the full-length model, the overall translocation process of colicin D is discussed.
Materials and Methods
Overexpression and purification of colicin D The expression of the C-terminal region of colicin D in E. coli was performed according to the method described previously (21), with some modifications. The expression plasmid encodes an operon consisting of ORFs coding for ColD313 (residues 313697 of colicin D) and C-terminally His 6 -tagged ImmD (94 plus 6 residues) under the control of the colicin promoter. At the N-terminus of ColD313, MetHis were added, due to the introduction of the initiation codon, by inserting a SphI site at the 5 0 of the ORF for ColD313. The E. coli strain W3110 harboring the expression plasmid was grown at 37 C in Luria-Bertani medium supplemented with ampicillin (100 mg/l). The expression of ColD313/ImmD was induced by the addition of mitomycin C to a final concentration of 200 ng/ml at an OD 660 of approximately 0.8, and the cells were further cultivated for 3 h. The cells were harvested by centrifugation and suspended in 50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl and 10 mM imidazole. The cell extract was obtained by sonication followed by centrifugation to remove the cell debris. The supernatant was applied to a HisTrap HP column (GE Healthcare, Buckinghamshire, England) pre-equilibrated with 50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl and 20 mM imidazole. The ColD313/ImmD complex was eluted with 50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl and 250 mM imidazole. The protein sample was dialyzed against 50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl, 20 mM imidazole and 6 M urea to partially denature and dissociate the ColD313/ImmD heterodimer. The sample was applied to a HisTrap HP column (GE Healthcare) with the same buffer to trap the His-tagged ImmD protein, and the free ColD313 protein was eluted and collected. The ColD313 protein was dialyzed against 20 mM Tris-HCl (pH 8.5) and applied to a Mono Q 10/100 GL column (GE Healthcare) equilibrated with 20 mM TrisHCl (pH 8.5). ColD313 was eluted with a linear gradient of 0500 mM KCl, dialyzed against 20 mM TrisHCl (pH 8.5), and concentrated by ultrafiltration (Vivaspin 20, 5000 MWCO PES; Sartorius, Go¨ttingen, Germany). The purity of the protein was confirmed by SDS-PAGE. A triple mutation (M344K/M345A/M352L), which eliminates the three clustered Met residues, was introduced for the crystallization of the selenomethionine (SeMet)-substituted ColD313 protein using a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) because the crystals did not grow when the original construct was used. The triple mutant showed improved reproducibility of the crystallization. The SeMet-substituted protein was expressed using a Met auxotroph E. coli strain, W2252, (33) and the cells were cultivated in M9 minimal medium supplemented with 50 mg/l L-SeMet. The procedures for expression and purification were identical to those of the native protein.
Size exclusion chromatography
The purified ColD313 was run on a Superdex 200 5/150 column GL (GE Healthcare) monitored by an HPLC system (Shimadzu, Kyoto, Japan). The column was equilibrated with 25 mM HEPES-Na (pH 7.5) containing 100 mM K 2 SO 4 , 0.025% n-dodecyl b-D-maltoside and 0.0025% cholesteryl hemisuccinate at a flow rate of 0.5 ml/ min. Marker Proteins for Molecular Weight Determination on Gel Filtration Standard (Bio-Rad, Hercules, CA, USA) were used as standards.
Size exclusion chromatography coupled with multi-angle laser light scattering (SEC-MALS) The ColD313 protein was concentrated to 1.0 mg/ml and applied onto an ENrich SEC 650 (10 Â 300 mm) column (Bio-Rad) in 20 mM TrisHCl (pH 7.5) buffer containing 150 mM NaCl. The MALS data were collected by a DAWN HELEOS 8 + detector (Wyatt Technology, Santa Barbara, CA, USA) with an RF-20A UV detector (Shimadzu) and were analyzed by the program ASTRA (Wyatt Technology).
Crystallography
The native ColD313 was crystallized at 20 C by the hanging drop vapour diffusion method using a reservoir solution containing 0.1 M HEPES-Na buffer (pH 7.5), 2.5% PEG400 and 2.2 M ammonium sulfate. The protein solution (10 mg/ml) was mixed with a reservoir solution at a ratio of 1:1. The SeMet-substituted ColD313 was crystallized using a reservoir solution containing 0.2 M ammonium sulfate, 0.1 M Bis-Tris (pH 5.5) and 25% PEG3350. The crystals were cryoprotected in a reservoir solution supplemented with 25% glycerol and were flash-cooled at 100 K in a stream of nitrogen gas. The diffraction data were collected at the Photon Factory of the High Energy Accelerator Research Organization (KEK, Tsukuba, Japan) and SPring-8 (Hyogo, Japan) and were processed using HKL2000 (34) . ColD313 contains 10 Met residues, and the remaining seven Met residues of the triple mutant were enough for the phase determination using the SeMet data set. The phase determination, model building and refinement were achieved using PHENIX (35) , and manual model building was performed using Coot (36) . The data collection and refinement statistics are shown in Table I .
Results
Crystal structure of CD-CRD We initially attempted to determine the crystal structure of full-length colicin D. Although purified full-length protein formed crystals under several conditions, they diffracted X-rays at very low resolutions (up to 8.3 Å ), even with the extensive effort of crystallization screening (data not shown). Next, a construct of residues 313697 (ColD313), which lacked the NTD but contains both the CD and CRD, was used for crystallographic analysis. Met311 and His312 were artificially introduced at the N-terminus during plasmid construction (see Materials and methods), and the molecular mass of the construct was 41,567. The crystal structure of ColD313 was solved by the single wavelength anomalous dispersion method using the SeMet derivative and was determined for the native protein at 1.85 Å resolution (Table I ). The crystal contained two molecules in the asymmetric unit (Fig. 2) . Three regions (Ile400Val403, Leu415Arg432 and Thr558Ser564 in chain A or -Asp565 in chain B) were disordered and were not included in the final model. The two molecules in the asymmetric unit are virtually the same, and the root mean square deviation (RMSD) for the Ca atoms between chains A and B was 0.18 Å . We will describe chain A, unless otherwise noted. The structure of the CRD in ColD313 was almost the same as those of the two CRD/ImmD structures that were independently determined (21, 23). The RMSD for the Ca atoms with PDB ID 1TFO (Fig. 1C) is 0.58 Å for 103 atoms of residues 595697.
The molecular masses of the purified ColD313 estimated by SDS-PAGE, size exclusion chromatography and SEC-MALS were 43.8, 45.3 and 40.0 kDa, respectively (Fig. 3) , indicating that this protein is monomeric in solution. This result is in sharp contrast with a previous study reporting that the fulllength colicin D is dimeric in solution (32) and that the NTD may be required for the dimerization. A possible cross-shaped dimer assembly of the full-length D/ImmD complex, as modelled by the two chains in the asymmetric unit (Fig. 2) , may exist outside the cell because modelled ImmD proteins do not interfere with the assembly (data not shown). However, the membrane translocation events and cleavage of the NTD presumably dissociate the protein into monomers.
Structural homologs of CD Currently, any protein structure having significant sequence homology (>30% identity) with the CD is not available. However, the C-terminal half of the CD (residues 452590) was assigned as a bacterial S-type pyocin superfamily (pfam06958), which also contains the NTD and the translocation domain of colicins D, B and E. A database search using the Dali server (37) revealed that the CD (331594) displayed weak but significant structural similarities (Z score510) to the translocation and N-terminal domains of colicins E3, E9, E7 and B, even though the sequence identities were below the detectable level by a BLAST search (520% , Table II) . A secondary structure matching-based database search using PDBeFold (38) also showed that the CD had a weak structural similarity with the translocation domain of ColE7 (PDB ID: 2AXC chain A; Q score = 0.186; RMSD = 3.2 Å ). The CD of colicin D and the NTD of colicin B share the relative positioning of their central three b-sheets and an associated a-helix (Fig. 4) . The core fold is commonly present in the import or translocation domains of both group A and B colicins (18, 3941) .
Construction of the full-length colicin D/ImmD heterodimeric structure model Our trials for the crystallization of the NTD of colicin D failed (data not shown). However, the NTD of colicin D shows very high sequence homology (95.2% identity and 97.4% similarity for residues 1313 by EMBOSS Needle pairwise alignment) (42) to the NTD of colicin B, whose full-length (two-domain) structure was determined (18) . In Fig. 5A , mismatch residues (15 in total) between the NTDs of colicins B and D are shown in magenta. We built a highly reliable homology model of this domain (global model quality estimation = 0.95) using the Swiss-Model server (43) , with the colicin B structure as a template. The NTD and pore-forming domain of colicin B are linked by a long ($74 Å ) helix (Fig. 5A ). Our ColD313 structure contains the C-terminal half of this helix (residue 313330, blue in Fig. 2) , and it shows a good structural alignment with the corresponding part of colicin B (brown in Fig. 5A ), as shown in Fig. 5B (RMSD for 18 Ca atoms = 0.26 Å ). Therefore, the homology model of the colicin D NTD was connected to the crystal structure of CD-CRD by aligning this region, and a single long linker helix between the NTD and the CD (Ser291Ala332) was modelled. Further structural alignment of the CRD with the CRD/ImmD heterodimer complex structure (Fig. 1C ) (21), in combination with the homology-modelled NTD, built the full-length colicin D/ImmD heterodimer structure, as shown in Fig. 5C . The full-length colicin D/ImmD structure exhibits a linear shape with a length of 150 Å consisting of three structurally distinct parts (NTD, CD and CRD/ ImmD). Three regions (400403, 558565 and 415432) of the CD were not modelled due to disorder in the CD-CRD crystal structure.
Discussion
Model of the import mechanism for colicin D Based on the full-length structure, we propose a model for the membrane translocation mechanism of colicin D into a target cell (Fig. 6 ). The first two steps are FepA receptor binding and TonB-dependent outer membrane translocation, according to the model suggested for colicin B (16) . The NTDs of colicins B and D basically have the same function because the two chimeric proteins, whose N-terminal 313 residues were swapped, exhibited full cytotoxicity to the wildtype E. coli cells (17) . Colicin D parasitizes the integral bacterial outer membrane porin protein FepA and the TonB system, which normally serve E. coli by importing the iron-binding siderophore as a surface receptor and an energy transducer, respectively (44) . FepA has a 22-stranded b-barrel structure (45) . The N-terminal small globular domain ($150 residues) of FepA is referred to as a plug, a cork, or a hatch and occupies the lumen of the barrel in the resting state. The extreme N-terminal region (residues 1218) of the cork domain (Fig. 1A) . Mutations in the C-terminal domain in TonB (R158S or P161L) abolished colicin D toxicity, and the toxicity was restored by suppressor mutations in the TonB box-like sequence (HTMVV or HSIVV) (47), demonstrating the functional interaction between these sites. The Ton complex consists of three integral membrane proteins, TonB, ExbB and ExbD (48) , and the energy of the proton motive force at the inner membrane is transduced to the outer membrane via TonB. ImmD may be dissociated from CRD during the proton motive force-coupled outer membrane translocation, which should involve (at least partial) unfolding of colicin D. In the next step, endoproteolytic processing is required for the translocation of the CRD across the inner membrane because a processed form (after residue 590) was detected in the cytoplasm of colicin-D-treated wild-type E. coli cells (20) . As mentioned, previous studies indicated that colicin D utilizes two inner membrane proteins, the signal peptidase LepB and the ATP-dependent protease FtsH, in this process (Fig. 6C, discussed below) (20, 22) . In the cytoplasm, the CRD of colicin D cleaves tRNA Arg s and exhibits cytotoxicity (Fig. 6D) (19) .
Architecture of the CD and possible protein interaction sites
The CD of colicin D ($280 residues) is unique among the >20 colicins studied so far (2) , and its function has been unknown for a long time (14) . Studies by de Zamaroczy and colleagues in the last 17 years established the function of the CD for inner membrane translocation (49) and identified possible regions and sites for interactions with TonB, ImmD (17) and LepB (32) . Here, we mapped these possible protein interaction sites on the crystal structure of the CD (Fig. 7A  and B) .
In addition to the major interaction site (MIS) of the TonB box-like sequence in NTD (15, 17, 47) , analysis of deletion mutants in the CD suggested that a region between 377 and 421 interacts with TonB as a second interaction site (SIS) (17) . In particular, three double mutations, F390C/F391Y, S404R/P405D and E420R/ E421R, in colicin D led to an almost complete loss of toxicity in the presence of the suppressor-type TonB box (HTMVV). The putative SIS for TonB (shown in yellow in Fig. 7A and B) includes the C-terminal half of a b-strand, an a-helix, a short-disordered region (400403), a b-strand and a half of the disordered region. The effective double mutation sites (shown in brown) are located inside the protein (Phe390 and Phe391) and around the disordered regions (Ser404, Pro405, Glu420 and Glu421). The a-helix (residues 385398) is located on the protein surface. However, we could not identify any structural features that may contribute to the supporting interaction with TonB in this region. In the study by Mora et al., the SIS for TonB was estimated by rough deletion mutants and drastic double mutations, in which hydrophobic residues were mutated to charged ones and vice versa (17) . These deletants and mutants could have altered conformation, which may have influenced on the interpretation of the results.
The well-established MIS for ImmD is solely located in the CRD. The buried surface area is wide ($1,900 Å ), and ImmD mimics the tRNA substrate structure through charge and shape complementarities (21, 23). Additionally, the presence of an SIS for ImmD in the CD was suggested. It has been shown that the MIS is sufficient to inhibit the minimal tRNase domain, and the SIS only supports the inhibition of longer constructs carrying the CD (17) . Even though no rough regions of the putative ImmD SIS were identified, several mutations (D571A, and E585A, and E420R/E421R) provoked a loss of immunity (17) . Mutational studies on ImmD suggested that the SIS possibly interacts with the a4 helix of ImmD, which is located on the opposite side of the MIS from the CRD (17) . As shown in the full-length model (Fig. 5C) , the CD and the tight CRD/ImmD Structure and membrane translocation of colicin D heterodimer complex form two structurally distinct domains, and apparently, there is no interaction between them. Two of the three disordered regions are rather short (four and eight residues for 400403 and 558565, respectively) and are unable to reach the distant a4 helix of ImmD. Two of the effective mutation sites (Asp571 and Glu585) are located in an internal b-strand of the CD scaffold (magenta in Fig. 7A and B). The other two sites (Glu420 and Glu421) are in the middle of the long-disordered region (18 residues for 415432) and may barely reach the a4 helix. Thus, our current structural model could not provide a rational explanation for the putative interaction with the SIS and ImmD. It is known that the expression of genes for colicin D and ImmD is translationally coupled. This coupling was possibly perturbed by the deletion or mutation within the region encoding CD, and ImmD might have failed to inhibit the tRNAcleaving activity.
A series of studies established a detailed mechanism of the LepB-FtsH-dependent inner membrane translocation of colicin D (Fig. 6C) (49) . The inner membrane protease FtsH, which is required for the cytotoxicity of all the nuclease colicins (31) , has been shown to endoproteolytically cleave the toxic domain (20) . Colicin D additionally requires the type I signal peptidase LepB for processing (22) , unlike other nuclease colicins. Although LepB is a serine protease that has a catalytic dyad of Ser90/Lys145, its catalytic activity is not required for colicin D import and processing (20) .
There is concrete evidence of the in vitro interaction between LepB and the LepB binding site (LBS, residues 410437) in the CD, as shown by the formation of a stable 1:1 complex during size exclusion chromatography and measurement of the affinity via surface plasmon resonance (K d = 2.0 nM at 37 C) (32) . In the crystal structure, the LBS (shown in orange in Fig. 7A and B) partly spans the flanking b-strands but is basically located in a loop region, which is predominantly disordered (415432). Therefore, the LBS appears to be suitable for interaction with other proteins, such as LepB. A mutational analysis of LepB indicated that several residues in the C-terminal conserved area called Box E (residues 272282, colored red in Fig.  6C ) (50) are involved in the interaction with the LBS (32) . Specifically, mutations of Asn274 to Ala and Asn277 to Lys strongly reduced this interaction. In addition, a spontaneous mutation of N274K in LepB resulted in the loss of sensitivity of E. coli target cells to colicin D (22) . In contrast, the catalytically inactive K145A mutant of LepB continued to strongly bind to colicin D and to restore the sensitivity of the N274K lepB mutant strain to colicin D (20) . The Box E region in LepB is located outside the catalytic site (S90/K145, colored magenta in Fig. 6C ) and subsites S1-S3 (or 1 to 3, blue circles in Fig. 6C ), which are responsible for the specificity to the N-terminal signal peptide region near the cleavage site (51) . The positive subsites (S1' and thereafter for the mature protein region ) have not yet been identified in the LepB structure, but the region around Box E exhibits a concave cleft and may accept a flexible peptide from other proteins.
LepB is normally involved in the secretion (export) of extracellular proteins from E. coli by cleaving the Nterminal signal (leader) peptide and by releasing the mature protein into the periplasm (52) . The proposed role of LepB in the import of colicin D is to ensure its stable association with the inner membrane (32) , which substitutes for the electrostatic interaction of other nuclease colicins with the inner membrane (31) . The 'bridging' function should be the prerequisite for the processing and translocation by FtsH. FtsH is an ATP-dependent protease belonging to the AAA+ family (53) . FtsH is involved in diverse cellular functions, but its main physiological role is considered to be quality control by the rapid elimination of abnormal membrane proteins and some short-lived cytosolic proteins. The involvement of FtsH in colicin import was also noted in studies of tolZ mutations, which show cross-tolerance to group A and B colicins (2830). FtsH preferentially acts on unfolded proteins rather than acting on the unfolding of the substrates themselves (54) . The widely exposed and flexible structural feature of the LBS of colicin D should be appropriate for the direct interaction with LepB and possibly for the partial unfolding process by the signal peptidase. The cleavage site between the CD and CRD (position 590, colored blue in Fig. 7) is buried in the present crystal structure. In addition to the strong interaction with the membrane-bound LepB handled at the LBS, the flexibility of the CD-CRD interface, as exemplified by the three disordered regions, allows us to assume partial unfolding of this region to expose the proteolytic cleavage site in the catalytic hexamer chamber of the cytosolic domain of FtsH. Interestingly, similar adaptor proteins that have chaperone-like functions are necessary for the degradation of natural substrates by FtsH. For example, the s 32 heat shock transcription factor is degraded by FtsH only in the presence of the chaperone DnaK (55) .
Implications of similarity to klebicins
In 2005, Chavan et al. reported phage-associated bacteriocins produced by the Gram-negative bacterium Klebsiella oxytoca, klebicin D and klebicin C, which carry a central domain partially similar to the CD of colicin D (56) . As shown in Fig. 7A (italicized numbers above the regions indicate the amino acid sequence identities with klebicin D), the C-terminal part of the CD (residues 422607) and the CRD show high conservation (>56% identity), while the NTD and the Nterminal part of the CD (residues 314421) are only weakly similar ($27% identity) (17) . The immunity proteins of klebicins also show high conservation with ImmD ($64% identity). The amino acid sequence conservation pattern suggests that klebicins also have tRNase toxicity but utilize a different outer membrane translocation system that is specific to Klebsiella. Accordingly, the in vivo toxicity of klebicin D against E. coli emerged when its whole N-terminal domain (residues 1317) was replaced by that of colicin D (17) . The result implies that the CD and CRD of klebicin D can utilize the LepB-FtsH system for inner membrane translocation. The amino acid sequence alignment of the LBS of colicin D and the corresponding region of klebicin shows the consensus motif of AG-GSD-VPGR (red characters in Fig. 7C ) (32) . BLAST searches using the amino acid sequences of E. coli proteins indicate that close homologs of LepB (identity $90%) and FtsH ($98%) are found in the genomes of K. oxytoca strains (data not shown). Moreover, the LBS consensus motif was identified in the complete genomes of 13 different bacterial species belonging to Gram-negative gammaproteobacteria, within nuclease-type bacteriocins that carry various import and/or catalytic domains (32) , suggesting that LepB is a common participant in their import.
Conclusion
In this study, we built a three-dimensional model of the full-length colicin D based on crystal structures and revealed the structural features of the protein interaction regions in the CD, especially those of the LBS. Moreover, the core fold of the CD was similar to the N-terminal import or translocation domains of both groups A and B colicins, suggesting that these domains share a common protein ancestor. The CD of colicin D might have exploited the structural scaffold of a bacterial S-type pyocin superfamily protein to install the specific interaction region with the signal peptidase LepB, which is commonly present on the periplasmic side of the inner membrane of Gram-negative bacteria. The LepB interaction can be used to gain a foothold in hijacking the FtsH-dependent processing system instead of the electrostatic interaction with the inner membrane that is commonly utilized in other nuclease colicins.
